Oxford Centre for Diabetes, Endocrinology and Metabolism
OCDEM is a pioneering centre that combines clinical care, research and education in diabetes, endocrine and metabolic diseases. By promoting world-class research, we aim to enhance understanding of these diseases and to accelerate the search for new treatments and cures.
Age-dependent changes in protein incorporation into collagen-rich tissues of mice by in vivo pulsed SILAC labelling
Ariosa-Morejon Y. et al, (2021), eLife, 10
Li M. et al, (2021), Nature Communications, 12
Verkouter I. et al, (2021), The Journal of Clinical Endocrinology & Metabolism
Genetic variant effects on gene expression in human pancreatic islets and their implications for T2D.
Viñuela A. et al, (2020), Nat Commun, 11
Haythorne E. et al, (2019), Nat Commun, 10
Whole genome sequence analysis identifies a PAX2 mutation to establish a correct diagnosis for a syndromic form of hyperuricemia.
Stevenson M. et al, (2020), Am J Med Genet A
13 July 2021
Queen Mary University of London and OCDEM researchers develop alternative treatment for patients as young as three months.
12 July 2021
People who get type 2 diabetes need to gain control of their blood-sugar levels — fast. The years immediately after diagnosis are strikingly critical in terms of their future risk for heart attacks and death.
View previous and upcoming events in OCDEM.